华兰疫苗跌6.6% 2022年上市见顶募22.76亿元

Core Points - Hualan Vaccine's stock closed at 23.07 yuan, down 6.60%, with a total market capitalization of 13.866 billion yuan, currently in a state of decline [1] - The company was listed on the Shenzhen Stock Exchange's ChiNext on February 18, 2022, with an initial public offering (IPO) price of 56.88 yuan per share [1] - On the first day of trading, Hualan Vaccine reached an intraday high of 79.78 yuan [1] - The total funds raised from the IPO amounted to 2.276 billion yuan, with a net amount of 2.244 billion yuan after deducting issuance costs of 31.5657 million yuan [1] - The actual funds raised were 251 million yuan less than the planned 2.495 billion yuan, which was intended for various vaccine development and production projects [1] - The total issuance costs for the IPO were 31.5657 million yuan, with the underwriter, Huatai United Securities, receiving a total of 22 million yuan in underwriting and sponsorship fees [1] Dividend Announcement - On May 30, 2023, Hualan Vaccine announced its 2022 annual equity distribution plan, which includes a cash dividend of 3.00 yuan for every 10 shares and a capital reserve conversion of 5 additional shares for every 10 shares held [2] - The record date for the equity distribution was set for June 6, 2023, with the ex-dividend date on June 7, 2023 [2]